We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New CVIS Solution Launched at the American College of Cardiology Conference

By MedImaging International staff writers
Posted on 22 Mar 2015
A new Cardiovascular Image and Information Management System (CVIS) has been demonstrated at the American College of Cardiology Annual Scientific Session (ACC; San Diego, USA), mid-March 2015.

CVIS is a central repository of data in a single integrated workspace that displays information about diagnosis, treatment, and therapy of patients across the whole cardiovascular service line.

The system is web-enabled and features tools for patient diagnosis and care planning, a suite of interoperable clinical modules, integrated echocardiography reporting, and tools for analyzing data for use by physicians, administrators, and researchers. The data analysis tools can be used to improve operational efficiency, increase productivity, as well as for insights into population health.

Jeroen Tas, CEO, Healthcare Informatics Solutions and Services at Philips, said, "The new era of value-based care and population health management is requiring cardiologists to collaborate and share information more readily with other care team members across various care settings. IntelliSpace Cardiovascular marks the next generation of cardiology imaging and innovation, serving as a layer of interoperability that allows all care team members to access data and sophisticated clinical applications within one workspace."

Related Links:

ACC Scientific Session
Royal Philips


Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Multi-Use Ultrasound Table
Clinton
Mammo DR Retrofit Solution
DR Retrofit Mammography
Medical Radiographic X-Ray Machine
TR30N HF

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.